LEGALZOOM.COM, INC. (LZ)

Financial Performance & Trajectory

LegalZoom is scaling steadily, with trailing revenue reaching $0.77B in Q1 2026, up from $0.73B in Q3 2025. The growth trajectory is clearly accelerating: YoY revenue growth improved from 7.7% in Q3 2025 to 10.9% in Q4 2025, and further to 13.3% in Q1 2026. This inflection suggests successful execution of go-to-market initiatives or product expansion. However, gross margin has compressed from 67.8% in Q3 2025 to 65.0% in Q1 2026, likely reflecting a mix shift toward lower-margin services or higher fulfillment costs. Free cash flow (FCF) margin remains robust at 16.7% in Q1 2026, though it has declined from 20.1% in Q3 2025, indicating increased reinvestment or working capital needs. The business is generating substantial cash relative to its revenue base, a hallmark of a mature SaaS model.

Operational & Go-to-Market (GTM) Efficiency

The Rule of 40 score—a composite of growth and profitability—has improved from 27.8 in Q3 2025 to 30.4 in Q4 2025, but dipped slightly to 30.0 in Q1 2026. This score remains below the 40-point threshold that investors typically reward, signaling that LegalZoom is still balancing growth and margin expansion. Net revenue retention (NRR) and CAC payback data are unavailable, making it difficult to fully assess cohort economics or unit efficiency. The gross margin compression and flat Rule of 40 suggest that recent reinvestments in sales and marketing may not yet be yielding proportional returns. The company appears to be in a transitional phase, prioritizing top-line acceleration over near-term efficiency gains.

Market Valuation & Sentiment

LegalZoom trades at a consistent 1.9x EV/Revenue multiple across the last three quarters, a modest valuation that reflects the market's cautious view on its sub-40% Rule of 40 performance and declining gross margins. Insider activity is bearish: the last 10 filings show zero buys and net insider selling of -$2,383.7K, signaling a lack of confidence from executives. Wall Street sentiment is mixed, with a consensus of "Buy" (5 buys, 4 holds, 3 sells) and an average price target of $8.17. This target implies limited upside from current levels, aligning with the multiple compression and insider selling. The valuation appears to price in steady-state growth but offers little premium for the recent acceleration, suggesting investors are waiting for proof of sustainable margin recovery.